ADRB2 and head and neck squamous cell carcinoma: β2AR contributes to an aggressive disease phenotype in a recurrent/metastatic model of HPV( + ) HNSCC and can be targeted with propranolol, a clinically available β-blocker, to inhibit primary tumor growth and metastatic development.